Talk:Signum Biosciences

This is the talk page for discussing improvements to the Signum Biosciences article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

New Jersey Low‑importance

	New Jersey portal This article is part of WikiProject New Jersey, an effort to create, expand, and improve New Jersey–related articles to Wikipedia feature-quality standard. Please join in the discussion.New JerseyWikipedia:WikiProject New JerseyTemplate:WikiProject New JerseyNew Jersey articles
Low	This article has been rated as Low-importance on the project's importance scale.

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Signum Biosciences.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

The following Wikipedia contributor has declared a personal or professional connection to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.

Sigrd (talk · contribs) / Signum Biosciences Signum Biosciences This user has declared a connection. (COI declared here)

Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent.

review

OK, I went through and removed all PRIMARY sources in this set of diffs - i did them one by one. In this set of diffs I checked each secondary source, and none of them mentioned the compound. at the end of that set of diffs, no sources in the article.

I then searched pubmed for SIG1273 and found two sources, both PRIMARY - PMID 25256809 and PMID 23174050, both by the same set of authors at Signum Dermalogix. Not independent :( another pubmed search for "Tetramethylhexadecenyl succinyl cysteine" gave one of those two.

OK, so no reviews, no independent sources indexed in pubmed.

What can we do here?

Did some digging, and it turns out there is a startup out of Princeton called Signum Biosciences website that has two subsidiaries - Signum Nutralogix and Signum Dermaologix. Signum Nutralogix in turn sells dietary supplements through a website called Mesports website. OK. So maybe turn this into an article on Signum Biosciences and merge the other article created by this user Eicosanoyl-5-hydroxytryptamide (this is the product sold by ME sports) into this.

OK, looking for sources and will do that. Jytdog (talk) 01:23, 11 April 2015 (UTC)[reply]

Jytdog great work, thank you ( oy. just oy) --Ozzie10aaaa (talk) 01:33, 11 April 2015 (UTC)[reply]

I don't think this is a real article. I don't think it would survive an AfD. There really are not good sources on this company either. Jytdog (talk) 03:20, 11 April 2015 (UTC)[reply]

you did get good refs (considering what you had to work with)--Ozzie10aaaa (talk) 11:18, 11 April 2015 (UTC)[reply]

Looks like this one should go to AfD. Even after substantial work by Jytdog the sources don't seem to support notability. - - MrBill3 (talk) 14:40, 15 April 2015 (UTC)[reply]

Agreed - the article gives no indication of significant notability. AndyTheGrump (talk) 00:52, 19 April 2015 (UTC)[reply]

I cannot argue with that. AndyTheGrump have a look at the original form of this article, and [[Eicosanoyl-5-hydroxytryptamide. Should they both go to AfD? ack Jytdog (talk) 02:24, 19 April 2015 (UTC)[reply]

you too MrBill3 Jytdog (talk) 02:25, 19 April 2015 (UTC)[reply]

Anthonyhcole thanks for reviewing the article. if you would also have a look at this article before i worked it over and its friend] before i redirected it here, and look at what i did as I described above, and let me know if we have ended up at a reasonable place or if we should just AfD both of them... or something else? i would appreciate that.

folks please note that i had an extensive discussion about COI and editing WP in general, with editor who created both these articles, see User_talk:Sigrd. Jytdog (talk) 04:55, 19 April 2015 (UTC)[reply]

Those are well-written and interesting articles but, for the reasons you've outlined on Sigrd's talk page they can't stay here. This is an exciting molecule and I wish the developers all the best with it. I think it's important that we do have the current article because there is already interest in the PD and AD communities, so we can point them to the existing secondary sources and hopefully add to that as more good independent reviews emerge. User: Sigrd, if you could keep this talk page up to date as new reviews emerge we'd really appreciate it. --Anthonyhcole (talk · contribs · email) 05:44, 19 April 2015 (UTC)[reply]